Reduced Disability

All Specialties

CME Events
REGISTER or LOGIN

/

Reduced Disability

ADVERTISEMENT

Reduced Disability

Article

Alemtuzumab May Be Superior to Interferon Beta-1a in Patients With MS—Results From the CARE-MS II Study

Author:: Reduced Disability

Publish date: June 1, 2012

Read More

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

MDEdge

About Us

Facebook
Linkedin
Twitter

Editorial Policy

Medscape Customer Support

Frequently Asked Questions

Advertise with MDedge

See more with MDedge! See our Other Publications

Copyright © 2025 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.